Supernus Pharmaceuticals (SUPN) FCF Margin (2011 - 2025)
Supernus Pharmaceuticals' (SUPN) quarterly FCF Margin came in at 9.19% in Q4 2025, down 1619.0% year-on-year from 0.6% in Q4 2024, and up 128.56% on a QoQ basis from 32.17% in Q3 2025.
Supernus Pharmaceuticals (SUPN) FCF Margin (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 15 years of FCF Margin data on file, last reported at 9.19% in Q4 2025.
- On a quarterly basis, FCF Margin fell 1619.0% year-over-year to 9.19% in Q4 2025; TTM through Dec 2025 was 6.4%, a 1947.0% decrease from a year earlier, with the FY2025 full-year figure at 6.4%, down 1947.0% from the prior year.
- FCF Margin for Q4 2025 stood at 9.19%, up from 32.17% in the prior quarter.
- Over the last five years, FCF Margin for SUPN reached as high as 41.8% in Q2 2022 and fell as low as 32.17% in Q3 2025.
- Historically, FCF Margin has averaged 18.05% across 5 years, with a median of 24.3% in 2023.
- Across the five-year window, FCF Margin jumped 3517 bps in 2024 and slumped 6252 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 30.66% in 2021, then tumbled by 46 bps to 16.57% in 2022, then soared by 65 bps to 27.38% in 2023, then decreased by 7 bps to 25.38% in 2024, then plunged by 64 bps to 9.19% in 2025.
- Per Business Quant data, the three most recent FCF Margin figures were 9.19% in Q4 2025, 32.17% in Q3 2025, and 35.1% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.19% |
| Sep 30, 2025 | -32.17% |
| Jun 30, 2025 | 35.10% |
| Mar 31, 2025 | 20.21% |
| Dec 31, 2024 | 25.38% |
| Sep 30, 2024 | 30.35% |
| Jun 30, 2024 | 21.13% |
| Mar 31, 2024 | 26.56% |
| Dec 31, 2023 | 27.38% |
| Sep 30, 2023 | 23.22% |
| Jun 30, 2023 | -14.04% |
| Mar 31, 2023 | 31.77% |
| Dec 31, 2022 | 16.57% |
| Sep 30, 2022 | 7.80% |
| Jun 30, 2022 | 41.80% |
| Mar 31, 2022 | 2.46% |
| Dec 31, 2021 | 30.66% |
| Sep 30, 2021 | -2.77% |
| Jun 30, 2021 | 32.74% |
| Mar 31, 2021 | 27.65% |